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Abstract  
Aims: To examine the prevalence of cognitive impairment in a Spanish elderly population and to analyse 
its association with some social and medical factors. Methods: We randomly selected a representative 
sample (n = 600) of people over 65 from Narón Council (A Coruña). Socio-demographic and biomedical 
data were collected and cognitive status was assessed using the Mini-Mental State Examination (MMSE). 
Results: We determined variations in the prevalence from 35.2%, when age or level of education 
distribution was not applied, to 22.2% when they were applied. Women showed a higher probability of 
cognitive impairment than men. Negative correlation was observed between the age of the subject and the 
MMSE secore (Spearman correlation p = -0.45, p < 0.001), with the possibility of developing cognitive 
impairment increasing each year. For our sample, cognitive impairment was associated with an increase 
of morbidity and mortality in the elderly population. This association was found with the presence of 
dementia. heart failure. anaemia, stroke and auditory deficits. Conclusions: Knowledge of the real 
prevalence rates, together with the establishment of adequate preventive and intervention measures, can 
be factors that may diminish the socio-sanitary impact of cognitive impairment. 
Introduction  
It is not clear if cognitive decline associated with old age is disease-related or whether it can occur as 
a part of so-called 'normal' ageing [1]. This 'normality' has been questioned, because subjects with 
cognitive deficits have been shown to be at increased risk for developing dementia compared to healthy 
control subjects [2, 3]. Moreover, several authors [4-8] have suggested an association between cognitive 
status and different pathologies like heart failure, stroke, diabetes, anaemia, hyperlipidaemia or sense 
organs alterations.  
Based on the above findings, estimates of the prevalence of cognitive impairment in the elderly 
population are essential, both due to its social impact and its rate of conversion to dementia as well as its 
association with other pathologies, which increases exponentially as the illness advances [9].  
There are various valid and reliable tools for clinical use and research for screening of people with 
cognitive impairment, such as the Short Portable Mental State Questionnaire [10]. the Mini-Cog [11] and 
the 7-min screening battery [12], among others, but the Mini-Mental State Examination (MMSE) 
developed by Folstein et al. [13], has become the most widely used and extensively studied method for 
assessing cognitive mental status [14].  
On the other hand, many studies have proved that age, sex, and level of education have important 
effects on the total MMSE scores [14-16], so that appropriate corrections must be done when estimating 
the prevalence of cognitive impairment in the population.  
The aim of this article was to determine the prevalence of cognitive impairment in a representative 
population of adults older than 65, reporting the effects of level of education, age and sex Secondly, we 
identified the pathologies associated with cognitive impairment because of their potential to increase 
mortality in this population.   
Methods 
Selection and Description o/ Participants  
The representative sample (n = 600) included people over 65 from Narón Council (A Coruña), 
randomly selected from the municipal register using a random number table and stratified by age 
quinquennia and sex (table 1, and ref. [17]). The level of confidence was 95%, accuracy ± 4% and 
estimation for data losses 10%. Nine subjects from the random sample were excluded due to data loss, as 
they were unable to be assessed with the MMSE be· cause of their minimal level of consciousness,  
Table 1. Distribution of the population by age group and gender, Naron 2000 
Age group Population 
 males (n = 2,339) females (n = 3,118) 
   
65-69 years 916 957 
70-74 years 653 779 
75-79 years 415 586 
80-84 years 209 400 
85 years and older 146 396 
   
Source: population data [17] 
 
Procedure  
Participants were community subjects, living at their home. Participants were individually assessed in 
a Health Centre or at home in the case of people with mobility difficulties. The study protocol was 
submitted to the Ethics Committee at the University of A Coruña. Before data collection, all participants 
were informed about the study and signed the corresponding informed consent.  
Variables and lnstruments  
Age, sex and level of education were included among the socio-demographic data. Data related to 
general health status and bio- medical parameters were also collected based on the following criteria [18]: 
Total cholesterol greater than 250 mg/dl and triglycerides 200 mg/dl or above was considered 
hyperlipidaemia; anaemia was defined by haemoglobin value less than 13 g/dl for men and less than 12 
g/dl for women.  
With regard to the remaining pathologies suffered (personal background and illnesses), data were 
obtained from the subject anamneses, collecting the answers given by the patient him/herself or his/her 
relatives according to the medical records.  
Cognitive impairment was modelled as a function of presence of hyperlipidaemia [high-density 
lipoprotein (HDL) and low-density lipoprotein (LDL) cholesterol], anaemia (haemoglobin level), 
haematocrit, creatinine, glycaemia, rheumatism. glaucoma, Parkinsonism, coronary disease, heart failure, 
diabetes, dementia, stroke, liver and kidney diseases, obesity, auditory and visual problems. This article 
only describes those with significant effects,  
The MMSE [13] was used to assess cognitive status. This questionnaire includes items assessing 5 
cognitive domains. A total possible score of 30 correspond to the highest cognitive status, with a cut-off 
score of 23 (lower or equal than 23) indicating cognitively impairment [13]. However, it has been proved 
that this cut-off score must be varied according to age and level of education, particularly when assessing 
an elderly population [19]. Crumer al. [l4] have examined the distribution of age and educational level 
with the MMSE score. Therefore, these different thresholds were used to obtain the cut-off median score 
according to age and level of education. The acceptance rate to undergo the MMSE test was 98.5%. Only 
591 participants were able to undergo the MMSE.  
A medical doctor (practitioner) and/or a trained nurse with extensive experience participated in the 
research for the clinical evaluation. This doctor was in charge of some of the patients during the research 
and also contacted other practitioners to follow the medical history of the rest of subjects to provide 
comprehensive ongoing knowledge of each patient’s status. Those subjects without medical records from 
their respective practitioner were interviewed by the research doctor to establish their medical history. 
The overall personal functional status and service use of elderly were assessed with a questionnaire based 
on the standardized questionnaire from the Older Americans Resources and Services Multidimensional 
Functional Assessment Questionnaire. The MMSE was administered by a qualified clinical psychologist 
with extensive experience in cognitive assessment.  
Statistics  
Measurement comparisons were made by means of the Student's t test and the Mann-Whitney U test. 
The Kolgomorov Smirnov test was performed previously to determine if the variables were normal or 
not, and so, a parametric or non-parametric test was used accordingly. The association of qualitative 
variables was estimated by means of the Xl statistic: the correlation among quantitative variables was 
estimated by the calculation of the Spearman p. In order to determine which variables modified a 
dichotomic dependent variable, a multiple logistic regression analysis was performed, with other 
variables introduced in the model as predictors, from which the odds ratios (OR) along with their 95% 
confidence intervals (Cl) were calculated. The results for continuous variables are given as a mean with a 
standard deviation (SO). The level of significance was p < 0.05.  
Statistical analyses were conducted using SPSS v. 16.0.1 [20].  
Results 
In (he sample, the mean age was 75.1 years (± 7.5 SD), with a mean age of 75.9 years (± 8.0 SD) for 
women and 73.9 (± 6.7 SD) for men.  
Differences were found in the prevalence of cognitive impairment, depending on the assessment 
criterion used to screen for cognitive impairment (table 2). In this sample, 35.2% (45.2% of women and 
22% of men) presented cognitive impairment according to the MMSE (cut-off at 23), when no 
distribution by age or level of education were made. These figures were substantially modified when 
applying the aforementioned distribution: 22.2% of the sample presented cognitive impairment, with 
significant differences (p < 0.001) by sex, 28.6% of women presented cognitive impairment versus 13.7% 
of men, being more likely to have cognitive impairment (OR = 2.19; 95% CI: 1.39-3.35). In general, 
women obtained a significantly lower mean MMSE score (p < 0.001) than men (22.6 ± 6.2 vs. 25.5 ± 4.2) 
within all age levels (table 3).  
Table 2. Prevalence rates for cognitive impairment by sex. MMSE cut-off 
scores by age and level of education [14] and cut-off at 23 
 n Prevalence (95% CI) 
MMSE (cut-off scores by age and educational level) 
Sex   
Men 35/255 13.7 (0.3-3.7) 
Women 96/336 28.6 (23.7-33.8) 
Total 131/591 22.2 (18.9-25.8) 
   
MMSE (cut-off at 23) 
Sex   
Men 56/255 22.0 (17.1-26.6) 
Women 152/336 45.2 (39.9-50.7) 
Total 208/591  35.2 (31.4-39.2) 
   
 
We observed a negative correlation between age of subjects and MMSE (Spearman correlation p = -
0.45, P < 0.001) score. Table 4 shows the distribution of the prevalence of cognitive impairment by age 
quinquennia, sex and level of education, establishing 23 as a cut-off or MMSE scores by age and level of 
education. Subjects presenting more cognitive impairment were those of higher age, i.e. older than 85 
years of age. The probability of developing cognitive impairment increases on a yearly basis (OR = 1.11; 
95% CI: 1.08-1.14), with the mean age of people with cognitive impairment higher than that of people 
without it (80.1 years vs. 73.6 years). Moreover, mean MMSE scores obtained for each age 
quinquennium indicate that, for both men and women, cognitive functioning significantly decreased (p < 
0.001) with age (table 3).   
Table 3. MMSE scores by age and sex (mean ± SD) 
Age, years Men Women Total 
    
65-69 26.4 ± 3.9 25.6 ± 3.4 26.1 ± 3.7 
70-74 26.8 ± 2.6 24.4 ± 5.8 25.5 ± 4.7 
75-79 24.8 ± 3.5 23.2 ± 5.1 23.9 ± 4.5 
80-84 24.3 ± 4.8 19.9± 5.6 21.5 ± 5.7 
≥ 85 22.6 ± 6.9 17.8 ± 5.5 19.3 ± 6.7 
    
Total 25.5 ± 4.2 22.6 ± 6.2 23.9 ± 5.6 
    
 
Level of education was also significantly correlated (p < 0.001) with cognitive impairment. Most of 
the subjects with cognitive impairment had less than 4 years of schooling.  
After carrying out a multivariate analysis associating cognitive impairment with the pathologies 
suffered by the sample subjects, we found an association between cognitive impairment and heart failure 
(p = 0.017), anaemia (p = 0.043), stroke (p = 0.016); dementia (p < 0.001) and auditory deficits (p = 
0.007). However, we did not find an association between cognitive impairment and hyperlipidemia, 
diabetes or eyesight problems.  
Discussion 
The results indicate that the prevalence of cognitive impairment varies considerably depending on the 
criterion used to screen for cognitive impairment [21], producing much higher figures when the 
appropriate corrections based on age and level of education are not made.  
It has been proven that sex has an important effect on the cognitive impairment, though it has not been 
considered in many studies [15. 16.22].  
Our results show that, for the same age level, there is a greater prevalence of cognitive impairment 
among women than among men. These data are in concordance with other authors' data [23-25], who 
suggest that this difference is more pronounced amongst people aged >80 years.  
Compared to these findings, significant differences (15) between both sexes were only found when 
comparing groups of men and women with low levels of education (less than 4 years of schooling). 
Amongst this group of individuals with a low level of education, men obtained better scores than women. 
In some cases, results are contradictory, as in the case of a Canadian sample, in which women obtained 
higher MMSE scores than men [22].  
Despite the results, we understand there is evidence of more cognitive impairment in women. More 
studies should be carried out to determine which factors are producing this clear result, which is unlikely 
solely due to higher mortality amongst men.  
In our study, the estimation of the prevalence for any type of cognitive impairment in an elderly 
sample was slightly higher than in other studies [23,26], in which approximately an 18% prevalence of 
cognitive impairment was found. Nevertheless, these differences may be related to the cut-off used in the 
MMSE when categorising the presence of cognitive impairment and the age level of the studied 
population. Consequently, the use of different categorisation criteria can produce some differences in 
prevalence across different studies, In our study, as we have already stated above, we have considered it 
more appropriate to determine the cut-off in the MMSE for each subject based on his/her age and level of 
education [14]. However, we also show the obtained figures without applying these criteria, finding 
differences for both sexes in all age groups. Thus, it is dearly shown how the prevalence of cognitive 
impairment increases when no distribution by age and level of education are applied.  
Different studies with elder1y European samples [3,27] showed rates of prevalence between 21 and 
27%, which are in concordance with those obtained in our study, once the influence of age and level of 
education are corrected. On the other hand, our results match those obtained in the Aging, Demographics 
and Memory Study (ADAMS), which was 22.2% 128J. In addition, the prevalence of cognitive 
impairment appears to be higher in developed countries than in underdeveloped areas, as observed with a 
prevalence of cognitive impairment of 10.4% in an elderly African sample [29].   
Table 4. Prevalence rates for cognitive impairment by age, sex and level of education, with [14] and without distribution of MMSE 
scores by age and educational level  
 Men   
 
Women   
 n  prevalence (95% CI)  
 
n  prevalence (95% CI)  
MMSE (cut-off scores by age and educational level)  
Age, years       
65-69  9/S5  10.6 (5,3-19.6)   11/87  12,6 (6,8-21.9)  
70-74  7/72  9.7 (4.32-19.8)   12/82  14.6 (8.1-24.6)  
75-79  9/50  18.0 (9.0-31.9)   22/67  32.8 (22.2-41.5)  
80-84  3/27  ll.\ (2.9-30.3)   18/48  37.5 (24.3-56.7)  
≥ 85  7/21  33.3 (14.5-56.9)   33/52  63.5 (48.9-76.0)  
Education, years       
0-4  26/195  13.3 (9.1-19.1)   86/304  28.3 (23.4-33.8)  
5-8  7/46  15.2 (6.8-29.5)   2/23  8.7 (1.5-29.5)  
9-12  1/11  9.1 (0.5-42.9)   0/3  0.0 (0.0-69.0)  
College or higher degree  1/3  33.3 (1.76-87.5)   2/2  100.0 (19.8-100.0)  
      
MMSE (cut-off at s 23)  
Age, ycars       
65-69  11/85  12.9 (6.9-22.4)   20/87  23.0 (14.9-33.5)  
70-74  9/72  12.5 (6.2-22.9)   24/82  29.3 (2D.O-40.5)  
75-79  17/50  34.0 (21.6-48.9)   31/67  46.3 (34.2-58.8)  
80-84  9/27  33.3 (17.2-54.0)   32/48  66.7 (51.5-79.1)  
≥ 85  10/21  47.6 (26.4-69.7)   45/52  86.5 (/3.6-94.0)  
Education, years       
0-4  53/195  27.2 (2l.2.-34.1)   143/304  47.0 (41.3-52.8)  
5-8  3/46  6.5 (1.7-18.9)   1/23  4.3 (0.21-24.0)  
9-12  o/u  0.0 (0.0-32.1)   0/3  0.0 (0.0-69.0)  
College or higher degree  0/3  0.0 (0.06-9.0)   0/2  0.0 (0.0-80.2)  
      
 
The risk of cognitive decline increases [30, 31] during the process of aging. In our study, we found the 
most significant increases in the prevalence of cognitive impairment (both for men and women) in the age 
range of 75-79, increasing again after 85 years of age.  
The greatest prevalence of cognitive impairment in the elderly has been found amongst those with the 
lowest levels of education [32], as was shown in our study, which reflects the situation in Spain (few 
people aged >65 years have more than 9 years of schooling). We did not have a homogeneous distribution 
with regard to the level of education, implying that the obtained percentages of prevalence for the highest 
level of educations are due to bias and do not represent the reality of OUT study sample. AI-though 
frequently used and practical, the MMSE is a relatively crude measure of cognitive impairment. It has a 
ceiling effect, which limits the detection of dementia in well-educated populations [33].  
On the other hand, there is evidence associating cognitive decline with certain pathologies, mainly 
heart disease, diabetes, stroke, anaemia, hyperlipidaemia, and sensory deficits [4-8]. Furthermore, 
longitudinal studies suggest that subjects with objectively demonstrated cognitive deficits, albeit without 
dementia, have been shown to be at increased risk of dementia, with rates of conversion estimated to be 
between 10% and 15% each year [2]. These figures go up to 18% over 3-year monitoring [3]. Due to this, 
cognitive impairment has been associated with a higher risk of mortality [34].  
Our results replicate other findings, which suggest a relationship between cognitive impairment and 
certain pathologies. In particular, we found that heart failure, stroke, anaemia, dementia and auditory 
deficits are significantly associated to cognitive impairment, In contrast, we could not estab1ish any 
association between cognitive detriment and diabetes or hyperlipidemia, replicating result from at least 2 
other studies, which also did not find either evidence of higher cognitive decline in a sample of diabetic 
elders [35J or an association between hyperlipidemia at baseline with change in cognitive test scores [7].  
In conclusion, there is a high prevalence of cognitive impairment among people aged >65 years, and it 
is more evident in women than men with increasing age. These rates should be corrected based on age 
and level of education criteria; otherwise, the estimated prevalence is too high. On the other hand, 
cognitive impairment is significantly associated with dementia and other health problems, such as heart 
failure, stroke, anaemia and auditory problems.  
Regular assessment of cognitive function should be performed on the elderly due to its important 
value as a predictor of morbidity and mortality.  
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